BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 24468753)

  • 1. Glucocorticoid-related bone changes from endogenous or exogenous glucocorticoids.
    Warriner AH; Saag KG
    Curr Opin Endocrinol Diabetes Obes; 2013 Dec; 20(6):510-6. PubMed ID: 24468753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Glucocorticoid-induced osteoporosis: recent findings].
    Angeli A; Osella G; Reimondo G; Terzolo M
    Ann Ital Med Int; 2000; 15(1):47-55. PubMed ID: 10842891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucocorticoid-induced osteoporosis: an update.
    Mazziotti G; Angeli A; Bilezikian JP; Canalis E; Giustina A
    Trends Endocrinol Metab; 2006; 17(4):144-9. PubMed ID: 16678739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Glucocorticoid-induced osteoporosis].
    Tóth M; Tulassay Z
    Orv Hetil; 2000 Jan; 141(5):219-23. PubMed ID: 10697979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis.
    Arthritis Rheum; 2001 Jul; 44(7):1496-503. PubMed ID: 11465699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucocorticoid-induced osteoporosis: a review on pathophysiology and treatment options.
    De Nijs RN
    Minerva Med; 2008 Feb; 99(1):23-43. PubMed ID: 18299694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How to prevent glucocorticoid-induced osteoporosis.
    Dore RK
    Cleve Clin J Med; 2010 Aug; 77(8):529-36. PubMed ID: 20682515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucocorticoids and Bone: Consequences of Endogenous and Exogenous Excess and Replacement Therapy.
    Hardy RS; Zhou H; Seibel MJ; Cooper MS
    Endocr Rev; 2018 Oct; 39(5):519-548. PubMed ID: 29905835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secondary osteoporosis: underlying disease and the risk for glucocorticoid-induced osteoporosis.
    Boling EP
    Clin Ther; 2004 Jan; 26(1):1-14. PubMed ID: 14996513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An update on glucocorticoid-induced osteoporosis.
    Woolf AD
    Curr Opin Rheumatol; 2007 Jul; 19(4):370-5. PubMed ID: 17551369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New data on the pathogenesis of steroid-induced osteoporosis: consequences for therapy and prevention].
    Hüfner M; Siggelkow H
    Dtsch Med Wochenschr; 2003 Jul; 128(30):1602-8. PubMed ID: 12884149
    [No Abstract]   [Full Text] [Related]  

  • 12. Glucocorticoid-induced osteoporosis.
    Berris KK; Repp AL; Kleerekoper M
    Curr Opin Endocrinol Diabetes Obes; 2007 Dec; 14(6):446-50. PubMed ID: 17982350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring and management of bone status in patients on chronic glucocorticoid treatment--the Medscheme experience.
    Rothberg AD; Matshidze PK
    S Afr Med J; 2000 Nov; 90(11):1125-9. PubMed ID: 11196035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Glucocorticoid-induced osteoporosis].
    Yasuda S; Kogawa M; Wada S
    Nihon Rinsho; 2003 Feb; 61(2):280-6. PubMed ID: 12638222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone safety of low-dose glucocorticoids in rheumatic diseases.
    Saag KG
    Ann N Y Acad Sci; 2014 May; 1318():55-64. PubMed ID: 24815076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucocorticoid-induced osteoporosis and its treatment.
    Pennisi P; Trombetti A; Rizzoli R
    Clin Orthop Relat Res; 2006 Feb; 443():39-47. PubMed ID: 16462424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adrenal incidentaloma: effects on bone metabolism.
    Francucci CM; Caudarella R; Rilli S; Fiscaletti P; Ceccoli L; Boscaro M
    J Endocrinol Invest; 2008 Jul; 31(7 Suppl):48-52. PubMed ID: 18791352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary prevention of glucocorticoid-induced osteoporosis with intravenous pamidronate and calcium: a prospective controlled 1-year study comparing a single infusion, an infusion given once every 3 months, and calcium alone.
    Boutsen Y; Jamart J; Esselinckx W; Devogelaer JP
    J Bone Miner Res; 2001 Jan; 16(1):104-12. PubMed ID: 11149473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deleterious effects of glucocorticoid replacement on bone in women after long-term remission of Cushing's syndrome.
    Barahona MJ; Sucunza N; Resmini E; Fernández-Real JM; Ricart W; Moreno-Navarrete JM; Puig T; Wägner AM; Rodriguez-Espinosa J; Farrerons J; Webb SM
    J Bone Miner Res; 2009 Nov; 24(11):1841-6. PubMed ID: 19453254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Glucocorticoid induced osteoporosis].
    Lange U; Müller-Ladner U
    Orthopade; 2007 Apr; 36(4):381-8; quiz 389-90. PubMed ID: 17665509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.